Intel
INTC
ASML Holding
ASML
Disney
DIS
Apple
AAPL
Salesforce
CRM
US Stock MarketDetailed Quotes
CMND Clearmind Medicine
- 1.2000
- +0.0600+5.26%
Close Mar 18 16:00 ET
- 1.2000
- 0.00000.00%
Pre 08:00 ET
6.16MMarket Cap-1.17P/E (TTM)
1.2000High1.1000Low40.08KVolume1.1800Open1.1400Pre Close46.12KTurnover0.86%Turnover RatioLossP/E (Static)5.13MShares2.300052wk High2.16P/B5.60MFloat Cap0.951252wk Low--Dividend TTM4.66MShs Float183.0000Historical High--Div YieldTTM8.77%Amplitude0.9205Historical Low1.1500Avg Price1Lot Size
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Clearmind Medicine Stock Forum
Breakthrough AUD Treatment Enters Human Trials: Yale, Johns Hopkins Back Clearmind's Novel Therapy
Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea
Monday, 10th March at 7:27 am
Vancouver, Canada, March 10, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems,...
Clearmind Medicine Announces Publication of Patent for Cocaine Addiction Psychedelic Combination Treatment in South Korea
Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico
Tuesday, 4th February at 8:35 am
Vancouver, Canada, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, annou...
this is just the beginning….
why this one no run with
$SciSparc (SPRC.US)$
Clearmind Medicine Advances Revolutionary Psychedelic Therapy for Binge Disorders with EU Patent Filing
SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment
Monday, 6th January at 7:50 am
TEL AVIV, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced today...
No comment yet